@article{JTD21731,
author = {Shingo Noguchi and Kazuhiro Yatera},
title = {Efficacy and immune activation of ipilimumab in early-stage lung cancer patients},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 17},
year = {2018},
keywords = {},
abstract = {Immune checkpoint inhibitors, such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) antibody and programmed death-1 (PD-1) antibody, improve the prognosis in several types of cancer patients, and they modulate the effector T-cell activation, proliferation and function (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/21731}
}